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The primary objective of this prospective questionnaire study was to determine
whether self-reported symptoms were predictive of nerve conduction study (NCS)
results. The population consisted of211 unselected patients with clinically suspected
carpal tunnel syndrome (CTS) who were physician referred for confirmatory NCS.
These patients were administered a pre-NCS questionnaire. Patients reported 350
symptomatic hands, and 72 asymptomatic hands. A comparison ofsymptom
lateralization and bilateral NCS results was performed. Standardized electrophysiologic
criteria were applied. In symptomatic hands, 49.2% ofNCS studies reported median
mononeuropathy, while, 50.8% were negative. In asymptomatic hands, 37.5% ofNCS
studies showed median mononeuropathy, the remaining 62.5% were negative. Overall
accuracy ofNCS compared to symptoms was 51.4%, with a sensitivity of 86.4%,
specificity of 20.1 %, positive predictive value of 49.1% and negative predictive value of
62.5%. These comparisons do not support a strong relationship between clinical
symptoms and NCS results in this patient group.
Abbreviations:
CTS
NCS
CTR
BMI
msec
mo
yr
kg
m
EMG
RUB
SDH
NSAIDs
ASA
cm
WCB
SD
CI
mmHg
RA
DM
ROC
carpal tunnel syndrome
nerve conduction study
carpal tunnel release
body mass index (kglm2)
millisecond
month
year
kilogram
metre
electromyogram
Royal University Hospital
Saskatoon District Health
non-steroidal anti-inflammatory drugs
acetylsalicylic acid
centimetre
workman's compensation board
standard deviation
confidence intervals
millimeters of mercury (units for measurement of tissue pressure)
rheumatoid arthritis
diabetes mellitus
receiver operator characteristic
Figure 1.1.1
The Anatomy of the Carpal Tunnel
boundaries. Ten structures have passage through the carpal tunnel: eight flexor tendons
to the four fingers, the flexor pollicis longus tendon and the median nerve [9].
The basic pathophysiologic abnormality in carpal tunnel compressive neuropathy
is understood to be one of increased pressure in the carpal tunnel. The tissue pressure
studied by wick catheter techniques within a compartment ofa limb is 7-8 mmHg under
normal circumstances. In carpal tunnel syndrome the pressure is often 30 mmHg, which
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is close to the level at which nerve dysfunction occurs [10, 11]. Flexion or extension of'
the wrist may result in pressure increases to 90 mmHg or more in carpal tunnel
syndrome. These pressures can have a two-fold effect on the nerve. The magnitude of
the pressure increase can result in ischemia. Supporting this premise is the finding that
systemic blood pressure influences the tissue pressure threshold at which nerve
dysfunction occurs. In a study of normotensive and hypertensive subjects, tissue pressure
thresholds at which median nerve sensory responses were completely blocked varied
from 40-50 mmHg for the normotensive to 60-70mmHg for the hypertensive. The tissue
pressure threshold was consistently 30mmf{g below diastolic blood pressure [12].
Chronic increased pressures and mechanic stress can also result in focal demyelination
and deformation of the myelin lamellae [1].
The pathogenesis of carpal tunnel sy:ndrome seems to be multifactorial.
Nonspecific flexor tenosynovitis has been tbleorized to be responsible for increased
pressure in many cases ofCTS [13]. Howewer, in some patients underlying medical or
physiological conditions are felt to be contrLbutory or predispose to neural susceptibility.
The most common of these include obesity, diabetes, hypothyroidism, and inflammatory
wrist arthritis [13,14,15,16]. A positive fa.mily history ofcarpal tunnel syndrome has
been reported as frequent in patients with CIS [17], as has cigarette smoking [18].
Treatment for this condition has tradritionally included volar splinting in the
neutral position, avoidance of movements re::quiring wrist flexion/extension, +/- NSAIDs.
Volar wrist splinting in the neutral position l1as been shown to be of benefit in improving
symptoms and electrophysiologic parameters in CTS [19,20]. Some studies have
suggested benefit from vitamin B6 supplem~ntation,others have not [21, 22, 23, 24].
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Studies ofcarpal tunnel corticosteroid injection have shown some benefit both
symptomatically and electrophysiologically [13,25]. Relapse rates are high [25,26,27,
28). It has been suggested that patients with mild symptoms and fmdings ofless than one
year's duration, normal sensibility, normal thenar strength and mass, and one to two
millisecond prolongations of either distal median motor or sensory latencies had the most
satisfactory responses to injections and splinting [29]. Age more than 50 years, duration
of disease for more than 10 months and constant paresthesias are all indicators that
conservative management will not succeed [30).
Surgical carpal tunnel release has been the definitive therapeutic intervention and
is highly successful [31]. In the Montreal study, the surgical incidence ofCTS was
0.9/1000 adults/year [32]. Many patients post carpal tunnel release will have delayed
return to full use of the hand [33]. Efforts have been made to identify patients who are
good surgical candidates by examination of pre-operative characteristics [34].
Diagnosis ofcarpal tunnel syndrome is based on history, physical examination,
and often electrodiagnostic testing. On history, patients often report numbness, tingling,
and pain in the hand which is generally more severe at night or after use of the hand. The
pain may radiate proximally into the forearm. The paresthesias and numbness are
generally in the median nerve distribution, involving the first three and a half digits with
sparing of the lateral aspect of the fourth digit and the entire fifth digit. Many patients
however, have difficulty in describing distribution of their symptoms and will report
entire hand involvement In more severe nerve compression, sensory loss will be
reported over some or all the digits affected. Physical examination findings may be
normal in early stages, and involve wasting of the thenar eminence and motor weakness
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in later stages. Sensory examination may be abnormal. Physical examination maneuvers
have been reported by many investigators to be of limited sensitivity and specificity in
diagnosis of carpal tunnel syndrome [35, 36, 37, 38]. Phalen's test (appearance or
worsening ofparesthesias with maximal passive wrist flexion for one minute) and Tinel's
sign (paresthesias in the median nerve distribution elicited by gentle tapping over the
carpal tunnel) are frequently utilized in assessment. Phalen's test has been shown to have
a sensitivity of75% and a specificity of47%. Tinel's sign has been associated with a
sensitivity of 60% and a specificity of67% [36]. The overall relationship of specific
physical examination maneuvers with symptoms and sensory electrophysiological test
results is weak.
The history and clinical examination ofcarpal tunnel syndrome may be mimicked
by proximal median nerve compression by muscles in the forearm such as the pronator
teres, lacertus fibrosus, and arch of flexor digitorum superficialis. Additionally, cervical
radiculopathy or diffuse peripheral neuropathy may confuse the clinical picture.
Electrodiagnostic testing (NeS) is employed to confmn neuropathology and to
distinguish compression at the carpal tunnel from other forms of neuropathy. Normal
ranges are based on latency distributions from multiple large group electrophysiologic
studies; an absolute sensory latency of more than 3.7 msec, a difference of 0.4 msec or
more between values obtained for the median nerve and those obtained for the radial or
ulnar nerve, a motor conduction latency of more than 4.2 msec, are all considered
abnormal (with control for the patient's age and limb temperature) [39]. Nerve
conduction studies are considered the "gold standard" for laboratory diagnosis ofcarpal
tunnel syndrome. The validity of this assumption has been called into question by
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several investigators [40, 41, 42]. In 1997, Concannon et al described a retrospective
study ofpatients with CTS symptoms who had undergone carpal tunnel release (CTR)
surgery. 13% ofpatients had negative NCS for CTS, but did not otherwise differ from
positive NCS CTS patients in symptoms, surgical outcomes or complications. They
reported a 13% false negative rate ofNCS in this population [40]. Homan et al published
a cross-sectional study of 824 workers showing poor overlap between reported
symptoms, physical examination findings and the electrodiagnostic study results. There
was poor concordance of symptoms and electrophysiological evidence of median
mononeuropathy. In that population, the majority ofpersons with electrophysiological
evidence of median mononeuropathy did not have symptoms of CTS and, conversely, the
majority of those with symptoms ofCTS did not have a median mononeuropathy [41].
Atroshi et al reported a CTS prevalence survey study from Sweden. In this study, 14.4%
of responders reported median nerve distribution sensory symptoms. Of these
symptomatic responders who underwent NCS, 45.8% had confirmatory
electrophysiologic studies. 18.4% ofan asymptomatic control population also met
electrophysiological criteria for median neuropathy. These observations call into
question the specificity ofelectrophysiologic diagnostic criteria for median
mononeuropathy [5]. This is an issue with practical implications as in today's medico-
legally conscious environment many surgeons require electrophysiologic confirmation of
CTS prior to considering surgical therapeutic intervention. Additionally, NCS results
carry weight in Workman's compensation cases or third party insurance claims. The
accuracy of this diagnostic tool has bearing on the potential level of care a patient may be
offered, as well as on the level ofcompensation which may be available.
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In this study we plan to further evaluate the diagnostic interplay between patient's
symptoms and nerve conduction studies in carpal tunnel syndrome. The utility of any
given diagnostic test is dependant in part on the population being tested and the pre-test
probability of the disorder in question. The workplace screening study reported by
Homan et al was initially a screening study of an asymptomatic population with a low
pre-test probability [41]. The population survey study reported by Atroshi et al, screened
a symptomatic population, however, this population was identified from responders to a
population survey [5]. In neither case was it likely that the study population would be
representative of patients presenting to their physician with complaints potentially
attributable to carpal tunnel syndrome. It is difficult to apply the findings from these
previous studies to the physician's office practice population. In this study the population
examined is made up ofpatients seen by their family physicians primarily. These
patients have all presented to their physicians with complaints suspicious of carpal tunnel
syndrome and have been referred for confirmatory nerve conduction studies to the
electrodiagnostic laboratory at Royal University Hospital. By examining this population
with a high pre-test probability ofcarpal tunnel syndrome; comparison ofsymptomatic
measures and symptom lateralization to nerve conduction study results can be made.
This study will permit further evaluation of the nerve conduction examination as a
diagnostic tool in the population for which it is primarily employed.
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1.2 Research Questions:
Primary:
In a population with a high pre-test probability of carpal tunnel syndrome, are
symptoms predictive of nerve conduction study results?
This will be examined by comparison of lateralization of patient symptoms and
nerve conduction study results. Comparison will also be made between symptom
characteristics of the population with positive nerve conduction study results and those
with negative results. These characteristics will include: duration of symptoms, a
symptom severity score, a functional severity score which reflects symptom impact on
patient function, and the use of treatment modalities as a limited proxy for symptom
severity.
Secondary:
1. What proportion of patients clinically suspected of CTS and referred for
electrodiagnostic studies by their physicians had confirmatory NCS results?
2. How common are previously reported risk factors for carpal tunnel syndrome in our
population?
3. What is the prevalence of use of conservative treatment modalities in a population
clinically suspected of CTS?
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(Appendix B) were reviewed and signed by those who agreed to participate. The
questionnaire was completed by the patient in the waiting area just prior to their
scheduled nerve conduction study.
2.31 Inclusion criteria:
1. The patient must have been referred for nerve conduction studies with median
nerve distribution symptoms as per requisition fonn.
2. The patient must be capable of understanding and agreeing to the questionnaire
application.
3. The patient must be 18 years of age or older.
2.4 Study duration:
Patients were recruited from the nerve conduction laboratory at Royal University
Hospital from January 2003 through November 2003 inclusive.
2.S Questionnaire design:
This survey (Appendix C) consisted offour domains:
1. Patient personal/demographic infonnation, including age, gender, hand
dominance, symptomatic hand(s), duration of symptoms, weight and height (Body Mass
Index (BMI) was calculated using kglm2 fonnula), and whether there was either lost work
time or workman's compensation claims related to CTS symptoms.
2. A validated CTS scoring instrument, the Levine questionnaire with
symptomatic and functional scores [43]. This tool was developed by Levine et al and
initially reported in The Journal of Bone and Joint Surgery in 1993. The authors reported
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evaluation of reproducibility, internal consistency, validity, and responsiveness to clinical
change of scales for the measurement ofseverity ofsymptoms and functional status. In a
sample of 38 CTS patients the scales were highly reproducible with Pearson correlation
coefficient r = 0.91 and 0.93 for severity of symptoms and functional status, respectively.
Internal consistency in a sample of 67 patients provided Cronbach alpha values of 0.89
and 0.91 for severity ofsymptoms and functional status respectively. Responsiveness to
clinical change was evaluated by follow up of38 patients post-CTR (median of 14
months post-op). The mean symptom-severity and functional-status scores improved
compared to pre-op values. Validity of the questionnaire was problematic as there is no
universally accepted standard for measurement of the severity of symptoms or hand
functional status. Both the symptomatic and functional scales had positive but weak
correlations with two sensory physical examination techniques; two-point discrimination
and Semmes-Weinsten monofilament testing (Spearman coefficient, r = 0.12 - 0.42).
Since publication, this outcome measure has been evaluated by other investigators and
used in several clinical trials.[ 44, 45, 46, 47] The original authors employed a mean
score for each ofthe symptomatic and functional scales. In this study the raw scores
were used to permit more effective use of parametric analysis. Higher scores are
associated with more severe symptoms and more severe functional impairment.
3. Self-reported potential risk factor assessment, including presence of associated
medical co- morbidities (diabetes mellitus, thyroid disease, pregnancy, rheumatoid
arthritis, ganglion, fibromyalgia, hypertension), or use ofassociated medications
(prophylactic ASA, antihypertensives, 'cardiac drugs', cholesterol lowering medication,
antidepressants, thyroid medications, hormonal therapy, oral contraceptives), smoking
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status, positive family history, and usual/most recent employment. Employment history
data was subsequently coded as: unskilled labour, housewife, farmer, professions
(primarily nursing and teaching professions), clerical workers, mechanical/machinery
worker, or no information provided.
4. Therapeutic intervention evaluation including: prescription/recommendation,
purchase, use of, adjustment ofand benefit from volar wrist splints;
prescription/recommendation, purchase, use of, and benefit from non-steroidal anti-
inflammatory drugs (NSAIDs), administration of and benefit from intra-carpal tunnel
corticosteroid injection, use ofvitamin B6 or multivitamins, and discussion of surgical
referral or actual surgical consultation. Benefit questions were structured as a 4 point
scale (yes, a great deal, yes, somewhat, uncertain, or not at all).
2.51 Questionnaire trial! Pilot data collection:
In order to evaluate ease of understanding of the question structures and language,
the questionnaire was initially administered as a trial to six volunteers with and without
hand symptoms. Subsequently, 25 consecutive patients were surveyed as a pilot study to
determine an estimate of unilateral versus bilateral proportions in this patient population.
These estimated proportions were employed in the sample size calculation for this study.
2.6 Samole Size:
The sample size for this study was based on the primary research question;
whether, in the population referred for NCS with suspected CTS, symptoms would be
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predictive ofNCS results. This would be primarily evaluated by comparison of
lateralization of symptoms and NCS results.
We anticipate two populations; those with unilateral symptoms and those with
bilateral symptoms. We therefore expect to compare NCS results in symptomatic hands
and asymptomatic hands. Based upon the pilot data an estimate that 30% of patients will
have unilateral symptoms was made. This means 15% of hands being tested by NCS will
be asymptomatic. This provides an allocation ratio of 5.5:1 (r = 5.5). The NCS results
will be either positive or negative for carpal tunnel syndrome. This gives a binary
outcome. Based on previous studies, the proportion of symptomatic hands expected to
have positive NCS is 0.5 (50%). The proportion of asymptomatic hands expected to have
positive NCS is 0.2 (20%). PA = 0.5, PB = 0.2 [5].
For this comparison ofNCS study results between symptomatic and asymptomatic hands,
the following equation was employed to calculate the number of patients required in each
group [48]:
Where m = patient number/group.
Where: () =PA-PS and p = (PA+ Ps)/2. ZI-aJ2 = 2.58, and Zl-P = 1.28 for a two-sided a =
0.01, and a ~ = 0.1
m = [2.58-V{2<O.7/2)(l-0.7/2U + 1.28-vW.5(l-0.5) + 0.2(l-0.2Uf
(0.5-0.2i
m = 72.857 or 73 hands/group. As, there is an unequal allocation ratio (r), a further
calculation is required: Given m, which was calculated assuming equal sized groups, m'
21
will be the sample size in the first group and un' will be the sample size in the second
group.
m'= L±.lxm
2r
m' = 43.07 or 44 hands (asymptomatic), and un' = 236.885 or 237 hands (symptomatic)
In teuns of people, this will equal 44 people with unilateral CTS, and 97 people
with bilateral CTS, for a total of 141 in both groups. A further 50% (71 patients) was
added to the total sample size desired to account for individuals who did not provide
appropriate signed consent (for questionnaire study itselfor access to electrophysiology
test results) or failed to complete the questionnaire. In summary, the sample size
proposed for this study was 212 patients.
2.7 Eledroohysiologic Data Collection:
Consent for access to medical records was a component of the study consent
foun. For those who completed the questionnaire and provided this consent, raw results
and the neurologist's interpretation ofelectrophysiology studies were accessed for each
study participant.
Bilateral studies are standard in our NCS laboratory regardless of whether patients
report unilateral or bilateral symptoms.
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2.71 Electrophysiological def"mition of CTS
A positive nerve conduction study for CTS was defined as demonstrating one or
more of the following characteristics [39,49]:
Median motor latency> 4.2 msec, Median sensory latency> 3.7 msec, orthodromic
Median palmar sensory latency (8cm) > 2.2 msec, antedromic wrist to palm (7cm)
Median sensory distal latency (wrist to digit 3 - palm to digit 3) > 2 msec. A difference
of 0.4 msec or more between values obtained for the median nerve and those obtained for
the radial or ulnar nerve.
2.8 Statistical Analysis
The data analysis for this study was based on the primary research question;
whether, in the population referred for NeS with suspected CTS, symptoms would be
predictive ofNCS results. This was evaluated by comparison oflateralization of
symptoms and NCS results in two group comparisons. However, as this study was in
part an exploratory hypothesis generating study with substantial descriptive data, multiple
testing was performed. Corrections for multiple testing were made using the Bonferroni
method as described below.
Data was entered into a computer spreadsheet. Continuous or numerical data,
were entered directly, categorical data was given a numerical code Le. for gender, male
was coded as 1, female was coded as 2. The numerical code was entered into the
spreadsheet for categorical or frequency data. SPSS version 12.0 statistical software was
utilized for data analysis.
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Continuous data was available for the following variables: age, symptom
duration, on a ratio scale, Levine symptomatic and functional scores, height, weight, and
BMI (directly calculated from height and weight) on an interval scale. Continuous data
when normally distributed permit use ofparametric analytic techniques. Characteristics
of the data were assessed; including measures ofcentral tendency, dispersion,
skewedness and kurtosis. Comparisons were primarily between two groups. This
allowed use oft-tests for two group comparisons. Independent 2-tailed t-tests were used
for comparisons ofcontinuous ratio/interval data between groups Two-tailed tests were
used rather than one-tailed in order to assess differences between the two groups in either
a positive or negative direction. When appropriate, 95% confidence intervals were
reported. In order to correct for multiple testing and avoid an increased risk of type I
error, the alpha value required before rejection of the null hypothesis was divided by k
(the number of comparisons made).
Frequency data (categorical, binomial, or count data) was generated for gender,
symptom lateralization, co-morbidities - present or absent, conservative treatment
utilization -yes or no, and occupational status. The chi-square distribution, which was
used in this study is the most commonly utilized statistical method for analysis of
frequency data. However, the chi-square test is not an appropriate method ofanalysis if
minimum expected frequency requirements are not met or if one of the expected
frequencies is less than five. Accordingly, Fisher's exact test was used when one or more
cell entries were less than five. Multiple testing correction of aIk were also performed.
For occupational categorical data, odds ratios were calculated for risk ofa
positive NCS in each occupational group. This technique was employed as the
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population consisted of those with a positive NCS and those without a positive NCS, the
distribution ofthe potential risk factor of occupation was retrospectively addressed The
95% confidence intervals for the odd's ratios was calculated using Woolfs formula [50].
Regression analysis was employed to determine independence ofvariables
associated with increased probability of a positive NCS. Binary-logistic regression was
utilized with the dichotomous outcome of a positive or negative NCS for CTS. Variables
were included by 'stepwise-enter' method. Variables were selected based on
demonstrated association with outcome in bivariate analysis. The Hosmer-Lemeshow
goodness of fit test was employed [51].
2.9 Ethical/Administrative Approvals:
Approval for this study was obtained from the University of Saskatchewan
Research Ethics Board (EC#: B2002-755), and the Saskatoon District Health Research
Services Unit.
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family's medical history. Pregnancy within the previous 6 months of the nerve
conduction study was reported in 1.4% (3) patients.
Current or most recent employment information was provided by 207/211 study
participants. The breakdown on occupational category in the study population revealed:
20.4% (43), were unskilled labour, 6.6% (14) were housewives, 4.3% (9) were farmers,
32.7% (69) were in the professions of nursing and teaching, 21.8% (46) were clerical
workers, 11.8% (25) were mechanical/machinery workers, and for 2.4%(5) no
information was provided [Figure 3.1.1].
Conservative treatment modalities were used in 55% (116) of the study
population pre-test. Wrist splints had been recommended in 33.2% (70) of patients, and
NSAIDs tried by 38.9010 (82) ofpatients. Corticosteroid injection to the carpal tunnel was
administered in 1.9% (4) of patients. Discussions with their doctor regarding surgical
referral were recalled by 31.8% (67) of the study population. 9.5% (20) had already seen
a surgeon for their current symptoms. Previous unilateral carpal tunnel release (CTR)
had been undergone in 7.6% (16) {right CTR in 5.7% (12), left CTR in 1.9% (4)} and
bilateral CTR in 1.4% (3) of study patients.
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Table 3.1.1: Personal characteristics of population in total
Characteristic Mean (SD) Range
Age for total population 46.72 (12.22) years 67 (21-88) years
Age for females (73.9%) 47.37 (12.40) years 67 (21-88) years
Age for males (26.1%) 44.85 (11.58) years 60 (23-83) years
Height for total population 165.42 (8.26) cm 43.20 (147.32 -190.5) cm
Weight for total population 80.22 (20.73) kg 140.90 (43.18 -184.09) kg
BMI for total population 29.25 (6.47) kg/m 36.69 (16.89 -53.55) kg/m
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Figure 3.1.1
3.2 Levine Scoring Instrument Application Analysis for Study Population
The Levine scoring instrument is a validated self-administered tool for
measurement of symptoms and function in carpal tunnel syndrome. The Levine
symptomatic and functional questionnaires were incorporated into the survey. Scores
were tabulated from each survey. The mean Levine symptomatic score for the total
population was 28.75. The minimum and maximum scores possible were 11 and 55. The
mean symptomatic score for the male population was 28.14 (SD 7.07), and for the female
population was 28.96 (SD 7.47) [Figure 3.2.1]. Comparisons of the symptomatic score
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means using 2-tailed independent t-tests showed no significant differences between
genders. The mean functional score for the male population was 13.46 (SD 4.37), and for
the female population was 15.61 (SD 5.34) [Figure 3.2.2]. Independent 2-tailed t-testing
comparison ofthe means showed a significant difference between genders with p =.009.
The mean Levine functional score for the total population was 15.05. The minimum and
maximum possible scores were 8 and 40 respectively.
gender differences in Levine symptomatic scores
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3.3 Nerve Conduction Study Results:
Nerve Conduction Study results [Figure 3.3.1], utilizing the previously mentioned
electrodiagnostic criteria for CTS were as follows:
For 57.3% (121) of patients, the NCS were confirmatory ofCTS
For 39.3% (83) ofpatients, the NCS were normal studies
For 3.4% (7) of patients, the NCS demonstrated non-CTS abnormalities
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Differences in age between groups were observed. The NCS positive group had a
mean age of49.08 years (SD 12.92), the NCS negative group had a mean age of43.54
years (SD 10.45) P = .001 (95% CI -8.81, -2.26) by independent 2-tailed t-test.
Age, BMI and its associated variable, weight showed significant differences
between groups in independent 2-tailed t-tests. Symptomatic score comparison was not
significant after correction for multiple comparisons, and substantial overlap in range
between the two groups is obvious [Figure 3.4.1]. No differences were seen between
groups in terms of functional scores, or frequency ofuse of conservative treatment
modalities. Symptom duration between NCS positive and NCS negative groups did not
differ. Examination of the gender groups revealed longer syIhptom duration in women
but not men, with positive NCS for CTS. These women had a mean symptom duration in
the NCS positive group of36.5 months and in the NCS negative group of21.2 months (p
= 0.025). When corrected for multiple comparisons, the p value was not significant.
Comparison ofpersonal characteristics revealed no significant differences in
gender between the two groups. The NCS positive group was comprised of 27.3% (33)
men, and the NCS negative group 24.4% (22) men, p = .643.
Assessment ofpotential risk factors and co-morbidities showed significant
increase in hypertension, associated use of antihypertensives (in all but one hypertensive
patient) and prophylactic ASA in the NCS positive population. As these characteristics
all increase with age, it was not clear that they could be viewed as independently
associated with increased likelihood of a positive NCS for CTS. Evaluation by logistic
regression did not confirm these variables to be independent of age. No differences
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between groups were seen in other co-morbidities or potential risk factors. Table 3.4.1.1
compares differences between the NCS positive and negative gf0ups.
Table 3.4.1.1: Comparison of CTS NCS positive and negative sroups
Variable NCS+(S.D.) NCS-(S.D.) Sig 95%CI 95%CI
n= 121 N=90 (2-tailed) Lower Upper
Mean age (years) 49.08(12.92) 43.54(10.45) .001 -8.81 -2.26
Gender (% male) 27.3%(n-33) 24.4% (n =22) .643
Mean duration symptoms 33.07(49.53) 24.21 (25.63) .095 -19.26 1.55
(months)
Height (cm) 165.02(8.35) 165.95(8.16) .422 -1.34 3.19
Weight (kg) 83.93 (22.90) 75.31(16.33) .003 -14.22 -3.02
BMI 30.61 (6.82) 27.45(5.50) <.001 -4.89 -1.43
Levine 29.82(7.46) 27.34(7.01) .016 -4.50 -0.47
symptomatic score
Levine functional score 15.40(5.52) 14.58(4.87) .267 -2.27 0.63
Workmissed n-29 55.2%(n=l6) 44.8%(n=13) .855
Workman's 38.5%(n=5) 61.5%(n=8) .215
Compensation cases
n= 13
Results expressed as mean values (standard deviation) unless otverwise specified
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From the clinical characteristic data gathered, logistic regression was employed to
confirm independence of variables associated with a positive NCS for CTS.
Using NCS positive or negative as previously defmed as the binomial dependant
variable, use of the independent variables, age, symptomatic score, and BMI in a logistic
regression provides the best model. These variables were chosen based on demonstrated
association with outcome in bivariate analysis. These three variables provide a model
with a chi squared of32.2 with 3 degrees of freedom and p < .001. The Homer and
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3.4.2 Comparison of occupational category
Information on most recent occupation was provided by 206 ofthe 211 study
participants. Table 3.4.2.1 compares differences between occupational groups.
Housewives, farmers, and unskilled labourers have higher odds of a positive test for CTS
than clerical workers, nurses or teachers in this population.
Table 3.4.2.1: Comparison ofoccupational category
Occupation Total Mean Mean %NCS+ Odds 95%CI
number age(yrs) BMI Ratios
Unskilled 43/211 44.0 28.90 30/43 (70%) 1.95 .95,4.00
labour (20.4%)
Housewife 14/211 52.2 26.74 12/14(86%) 4.84 1.06,22.20
(6.6%)
Farmer 9/211 (4.3%) 43.3 35.33 7/9 (78%) 2.70 0.49,15.0
Clerical 69/211 46.3 29.06 30/69(43%) 0.43 0.24,0.77
worker (32.7%)
Professions 46/211 48.4 29.32 24/46(52%) 0.76 0.39,1.47
(21.8%)
Machinery 25/211 41.8 29.32 14/25 (56%) 0.94 0.23,1.25
operators (11.8%)
No info. 5/211 (2.4%) 74.8 29.47 4/5 (80%) 3.04 .33,27.67
Provided
3.5 Comparison of Lateralization of Presenting Symptoms and NCS Results
This portion of the analysis compares the symptom lateralization self-reported by
patients and the NCS results, addressing directly the primary research question posed.
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Seventy-two (34.1%) patients reported unilateral symptoms, in contrast to 139
(65.9%) reporting bilateral symptoms. This proportion of patients with unilateral
involvement was quite consistent with the pilot data employed in sample size estimation.
Patients with unilateral symptoms did not differ from those with bilateral symptoms in
demographics, co-morbidities, symptomatic scores, functional scores, or frequency of
conservative treatment recommendation. Symptom duration did differ between groups.
Patients with unilateral symptoms had a mean symptom duration of 18.5 months, while
those with bilateral symptoms had a mean symptom duration reported of34.9 months (p
=0.001).
A comparison between: presenting symptom lateralization and NCS results, was
possible, as bilateral NCS is standard laboratory protocol whether a patient has unilateral
or bilateral symptoms. These results are outlined in Table 3.5.1. A comparison ofNCS
findings by hand dominance is also made. There was substantial discordance between
lateralization ofCTS symptoms (left, right or bilateral hand symptoms) and NCS results.
Whether CTS symptoms were unilateral or bilateral, 31-44% ofNCS were negative. The
group reporting bilateral symptoms had the highest degree ofagreement with the NCS
with 38.9% concordance. Unilateral NCS abnormalities were seen in 18% of the bilateral
symptom group. Isolated right sided symptoms were more often in agreement with NCS
results than isolated left sided; 25.6% versus 13.8%. Discordant fmdings, either bilateral
median neuropathies or isolated opposite side median neuropathies, were seen on NCS in
25.6% of patients reporting isolated right sided symptoms, and in 55.2% of those
reporting isolated left sided symptoms. Interestingly, although patients with isolated left
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median mononeuropathy were seen in the right hand dominant population, they were not
seen in the left hand dominant population.
A comparison ofNCS results in symptomatic and asymptomatic hands was
possible. Examination by individual wrists is outlined in Table 3.5.2, where presence or
absence ofclinical symptoms suspected to be CTS are compared to NCS results (as
previously defined). From this perspective, employing the NCS as the 'gold standard',
the following comparative characteristics were calculated for diagnosis by symptoms:
sensitivity of 86.4% (172/199), specificity of20.1 % (45/223), positive predictive value of
49.1% (172/350), negative predictive value of 62.5% (45/72), accuracy of 51.4%
(217/422), and prevalence ofdisease (pre-test probability in this population) of47.1%
(199/422). The positive likelihood ratio was 1.13, indicating a patient reporting
symptoms was 1.13 times more likely to have a positive NCS study than those without
symptoms in this population. The negative likelihood ratio was 0.70. These comparisons
do not support a strong relationship between clinical symptoms and NCS results in this
patient group.
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Table 3.5.1: Comparison of symptom lateralization and NCS results
NCSresult
Bilateral Bilateral Isolated Isolated Other
Negative Positive right left non-CTS
positive Positive abnormality
Bilateral 39.6% 38.9% 10.8% 7.2% 3.6%
(55/139) (54/139) (15/139) (10/139) (5/139)
Lateralization Isolated 44% 25.6% 25.6% 0 4.6%
of symptoms right side (19/43) (11/43) (11/43) (2/43)
Isolated 31% 44.8% 10.4% 13.8% 0
left side (9/29) (13/29) (3/29) (4/29)
Right 39.3% 36.1% 13.6% 7.3% 3.7%
Hand (75/191) (69/191) (26/191) (14/191) (7/191)
dominance Left 40% 45% 15% 0 0
(8/20) (9/20) (3/20)
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Table 3.5.2: Comparison of number of symptomatic wrists with NCS results
NCS Results for CTS
Positive Negative Total
ISympromatic Yes 172 178 350
Wrist No 27 45 72
Total 199 223 422
3.6 Conservative treatment measures:
Conservative treatment measures had been offered to approximately halfof these
patients with clinically suspected carpal tunnel syndrome (Table 3.6.1). Only 33.2%
(70/211) of the study population had been prescribed wrist splints. 69170 purchased the
wrist splints, and 13% (9/69) had undergone adjustment of the splint for optimal
treatment. Reported compliance with splint usage varied with 38/69 (55%)
usually/always wearing splints at night, compared to 20 (29%) who reported occasional
night time use, and 11 (15.9010) who stated they never wore their splints at night.
Daytime usage ofmore than 6 hours was reported by 21 (30.4%) patients. Eighteen
(26.1%) patients reported usage for 2-6 hours/day. The remaining 29 (43.5%) patients
reported one hour or less of wrist splint use each day. The majority of patients did not
usually wear their splints to their workplace, with 28 (40.6%) reporting never doing so.
A further 28 (40.6%) of patients with wrist splints occasionally wore them to work. Nine
(13%) patients usually/always wore their splints to work, and the remaining four of the
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sixty-nine patients reported no workplace outside the home. Improvement in symptoms
perceived to be related to wrist splint use was reported in 54/69 (78.3%) patients.
However, 25 of these 54 successfully treated patients had negative NCS.
NSAIDs were prescribed/recommended in 52/211 (24.6%) patients, but 82/211
(38.9%) had purchased/tried NSAIDs. As several NSAIDs are non-prescription
medications, this discrepancy was expected. The mean reported duration of use of
NSAIDs was 17.8 months (SD 30.9) with a range of203 (1-203 months). Improvement
perceived to be related to NSAID use was reported in 61/82 (74.4%). However, 28 of
these 61 successfully treated patients had negative NCS. These patient numbers
reporting improvement were arrived at by collating the number ofpatients who
responded with; yes, a great deal or yes, somewhat; to the questions on benefit for splint
use or NSAID use. Thirty-five patients were prescribed/used both splints and NSAIDs.
In this subgroup, 85.7% (30/35) reported improvement. Interestingly, there were no
significant differences between the NCS positive and negative groups in reported
improvements with splints or NSAIDs. Patients prescribed these therapeutic
interventions did not differ in age, BMI, gender, duration of symptoms, symptomatic or
functional scores from the remainder of the population. Patients responding to NSAIDs
and/or splinting did not differ from non-responders in terms ofLevine symptomatic,
functional scores, age, gender, BMI, or duration of symptoms. In all 55% (116) patients
had used wrist splints and/or NSAIDs.
No significant difference in vitamin usage was noted between the diagnostic
groups.
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Table 3.6.1: Conservative treatment utilization
Treatment Total population CTS + group CTS-group Significance (2-tailed)
(n=211) (n= 121) (n=90) (pvalue)
NSAIDs: 52(24.6%) 26(21.5%) 26(28.9"10) .200
prescribed
NSAIDs: 82(38.9"10) 45(37.2%) 37 (41.1%) .520
use reported
Wrist splints: 70(33.2%) 38(31.4%) 32(35.6%) .583
prescribed
Wrist splints: 69(32.7%) 37(30.5%) 32(35.6%) .471
obtained
NSAIDs&/or 116(55%) 63(52.1%) 53(58.9%) .325
splint use
VitaminB6 18(8.5%) 12(9.9"10) 6(6.7%) .410
lntra-earpal 4(1.9"10) 1(0.8%) 3(3.3%) .313
corticosteroid
injection
3.7 Questionnaire Defects:
Upon reviewing the completed questionnaires it became apparent despite initial
testing of the instrument that one question was flawed and data from it was not
interpretable. This error in question design occurred for Question 46 where the question
was not structured clearly enough to distinguish the postmenopausal woman on no
hormonal supplements from the premenopausal woman on no hormonal therapies. This
could have been prevented by a wider population demographic for the questionnaire trial
and an earlier evaluation of the completed questionnaires.
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symptomatic improvement with use. No increase in frequency ofNCS positive
individuals was seen in either the patients prescribed or responding to splinting/NSAIDs.
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5.2 Conservative Treatment Utilization:
This study also assessed the prevalence of pre-test therapeutic interventions.
These 'conservative' therapeutic options included use ofwrist splints, NSAIDs, intra-
canal corticosteroid injection and vitamin B6 use. Wrist splinting has been shown by
several studies to be efficacious in relieving symptoms ofcarpal tunnel syndrome [19,
20]. The intra-carpal pressure in CTS as determined through Wick catheter
measurements is tremendously elevated with flexion and extension, the lowest pressure
transduced in CTS patients has been in the neutral position [52]. Not surprisingly, the
wrist splint positioned in a neutral angle provides superior symptom relief compared to
other splinting angles [53]. Significant improvement in both sensory and motor distal
latencies has been observed in full time use ofwrist splints compared to night use only
patients [19]. Corticosteroid injection has also been shown to be efficacious in relief of
symptoms ofCTS [25,26,29,54].
Considering both NSAIDs and wrist splints, 55% of the study population received
either or both of these treatments. The ratio ofNCS positive/ negative was
approximately equal between the treated and untreated groups for both NSAIDs and wrist
splints. No differences in Levine symptomatic, functional scores, age, gender, BMI, or
duration of symptoms were observed between the treated and untreated groups or
between the responders and non-responders. The response to treatment measure utilized
in this study was quite subjective, depending on patient recall ofresponse. Limited
conclusions from this retrospective approach can be drawn regarding efficacy of these
therapeutic interventions in this study. Intra-articular steroid injection was used in only 4
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It would seem in this patient population that non-invasive conservative treatment
modalities, despite previous reports ofefficacy, are recommended or utilized in only half
of the patients referred for NCS with symptoms of CTS.
5.3 Diagnostic Utility of Self-Reported Symptoms in CTS:
The issue ofdiagnostic clarity creates difficulty in epidemiologic research in CTS.
A combination ofconsistent symptoms, physical exam signs and electrophysiological
findings would be compelling in diagnosing CTS. However, physical exam signs have
been evaluated by many investigators and found to be wanting in sensitivity and
specificity in relation to symptoms and NCS results. A self-administered hand diagram
in the diagnosis ofcarpal tunnel syndrome has been shown to have a sensitivity of SOOIo
and specificity of 90% [55]. This is superior to most physical examination maneuvers.
The nerve conduction study is often held to be the "gold standard" in providing some
measure ofobjectivity in assessing patients with median nerve distribution symptoms or
signs. As previously mentioned, the validity of this assumption has been called into
question by several investigators [40,41,42]. In this patient population, with clinically
diagnosed or suspected CTS, 39.3% had completely normal or negative
electrophysiologic studies. It should be pointed out that the majority of the referring
physicians were family practitioners and not musculoskeletal specialists or neurologists.
The argument could be made that family practitioners may be less skilled at clinical
evaluation of potential carpal tunnel syndrome than specialists leading to a higher number
of negative studies from a lower pre-test probability. On the other hand, as has been
mentioned, the physical examination for carpal tunnel syndrome has imperfect sensitivity
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and specificity even in a clinical trial setting. Accordingly, our finding of39.3% negative
studies may be a reflection of poor specificity of the clinical screening process, and/or
limited sensitivity of the NCS. The questioning of sensitivity and specificity of clinical
diagnostic maneuvers, reported symptoms, and nerve conduction studies leave the
clinician without a reliable standard on which to base a diagnosis of carpal tunnel
syndrome, or rule that diagnosis out. Likewise, arriving at a case definition of CTS for
future research which would be widely accepted may be problematic.
In this study, the primary objective was to compare the diagnostic utility of self-
reported symptoms to NCS results. A methodological criticism could include the
absence ofa patient completed hand diagram in the data collection. However, a
physician-completed hand diagram is included in the NCS requisition form for each
patient (Appendix A), and specific symptom lateralization is a component of the
questionnaire.
Symptom characteristics between the NCS positive and negative groups revealed
no difference in frequency of conservative treatment use, lost work time, workman's
compensation claims, or Levine functional score. Intuitively, one would expect a higher
symptomatic score to be associated with a positive NCS result. There was indeed such a
difference observed in the Levine symptomatic score between groups, but when corrected
for multiple comparisons lost significance. This is not surprising when the extent of
overlap in symptom score ranges between groups is observed.
A wide range of symptom duration was seen in the population, from 1 up to 300
months was reported. The duration of hand symptoms was not predictive for a positive
NCS. The mean duration was 29.3 months, suggesting many people tolerate their
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symptoms for aprolonged period, prior to seeking medical advice. This implies a large
number ofun.t'l:p<>rted or unrecognized CTS may exist in the general population. This
tolerance of symp~omswas also reflected in the relatively small numbers of people in this
study populatioo '-Vho reported missing work or filing WCB claims due to their hand
symptoms. Patients with unilateml symptoms reported shorter symptom duration than
those with bilateral symptoms.
The su~or sensitivity and specificity ofthe hand diagram in diagnosis ofCTS,
suggests that seIf-~eported symptom lateralization would be predictive ofNCS results.
This was not the case. Assuming accuracy of reporting on the part of the patients in
terms oflateralization of their symptoms, marked discordance was evident in the
comparison with NCS results. In terms of symptomatic hands; there was confirmation in
the form ofa positive NCS in 49.2% of symptomatic hands. A negative NCS was seen in
50.8% of symptorDatic hands. In terms ofasymptomatic hands; concordance with a
negative NCS was seen in 62.5% of asymptomatic hands. Asymptomatic hands were
found to haveJXls-tive NCS for CTS in 37.5% ofcases. The overall accuracy of symptom
lateralization fir NCS results was 51.4%.
It has beer1 suggested that patients with asymptomatic median mononeuropathy
may have subclinical CTS. In this study, the observation that those with unilateral
symptoms hadshorter symptom duration than those with bilateral symptoms would fit
with that possilXli-t;y. However, if this is the case, it is reasonable to expect an abnormal
NCS in these iJdi"iduals to be predictive of future symptom development. Although
limited observati~ s have been made, this has not been confirmed in other studies. This
question was prtially addressed by Nathan et at in a longitudinal study of289 workers in
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four industries, who compared NCS results with symptoms and found that 82% of
subjects with abnormal NCS results had persistence ofNCS slowing over time, but
symptoms fluctuated substantially, with only 13% having persistent symptoms over the
eleven year follow-up period [56]. Another case control study of over 700 workers in
five sites found 77 asymptomatic workers with NCS evidence of median
mononeuropathy and compared them with a control group of normal NCS subjects who
were age and sex matched. A follow-up questionnaire 6 months later found no difference
in percentage of subjects reporting CTS-like symptoms between the two groups [57].
These observations, as well as the findings of this study create confusion as to the
role ofNCS in diagnosis ofCTS. It is likely that diagnostic utility varies with the pre-test
probability of a population, and very likely varies in subpopulations depending on
susceptibility of neural elements to insult.
In clinical practice, substantial weight may be placed on NCS results; influencing
referral for surgical intervention as well as prescription of non-surgical interventions.
Further evaluation of sensitivity and specificity of standardized nerve conduction studies
would be clinically relevant. Ideally, the NCS could be studied in comparison with
another "gold standard" diagnostic measurement. Potentially, intra-carpal pressure
measurements may be an appropriate comparison for nerve conduction studies. Wick
catheter measurements in previous studies have demonstrated substantial differences
between the intra-carpal pressure in a normal and a wrist with CTS [11]. However,
problems may arise with utilization ofabsolute intra-carpal pressures as a standard for
diagnosis in CTS. Variation in median nerve susceptibility to pressure injury due to pre-
existing vascular, metabolic disease likely exists between populations. Diabetes mellitus
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is a recognized example of a disease state that may put individuals at increased risk of
compressive median neuropathy [58]. Familial predisposition to compressive neuropathy
also exists [17, 59]. It is probable, that lower intra-carpal pressures are required to create
clinical CTS in a susceptible individual than in a non-susceptible individual. Age related
changes in neural susceptibility to compression are also likely. This would potentially
create difficulties in defining a pathologic range of intra-carpal pressures for comparison
with electrophysiologic test results.
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Appendix A: NCS Requisition Form
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Appendix B: Consent form:
Consent Form
You are invited to participate in a study entitled" A survey of patients with
median nerve distribution symptoms presenting for nerve conduction studies"
Please read this form carefUlly, andfeel free to ask questions you might have.
Researchers: Dr. R.M. Taylor Gjevre, Dr. B. Nair, Dr. J. Sibley, Division of
Rheumatology. Dr. C. Boyle, Division ofNeurology, Ms. C. Geddes, Neurophysiology
Laboratory, Royal University Hospital, University of Saskatchewan. Contact number:
966-8280,
Purpose and Procedure: This study is in the form ofa questionnaire. The purpose of
the study is to find out what kinds of non-surgical treatments patients with hand/wrist
symptoms are using. Also we wish to see if we can predict, based on people's symptoms
who will have a positive nerve conduction test. For this purpose, as part of this study, we
request permission to review your nerve conduction test results
Potential Risks or Benefits: No risks would be involved. There would be no direct
benefits to the participant.
Storage of Data: The questionnaire information will be stored for 5 years in a locked file
cabinet in Dr. R. Taylor Gjevre's office. Only the researchers involved will have access.
Confidentiality: When the study is complete the group results will be submitted to
medical journals and/or medical conferences. Complete individual confidentiality and
anonymity would be guaranteed in presentation or publication ofresults.
Right to Withdraw: You may withdrawfrom the studyfor any reason, at any time,
without penalty ofany sort (and without loss ofrelevant entitlements, without affecting
academic or employment status, without losing access to relevant services etc.) Ifyou
withdraw from the study at any time, any data that you have contributed will be
destroyed
Questions: Ifyou have any questions concerning the study, please feel free to ask at any
point; you are also free to contact the researchers at the numbers provided above ifyou
have questions at a later time. This study has been approved on ethical grounds by the
University ofSaskatchewan Behavioural Sciences Research Ethics Board on Jan. 15/03.
Any questions regarding your rights as a participant may be addressed to that committee
through the Office ofResearch Services (966-2084).
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We ask you below for permission to review your records for medical research:
I agree to allow information from my medical record to be reviewed for medical research.
I understand that this information will remain confidential.
Please put an X in one box. Thank you! DYes DNo
Consent to Participate: I have read and understood the description provided above; I
have been provided with an opportunity to ask questions and my questions have been
answered satisfactorily. I consent to participate in the study described above,
understanding that I may withdraw this consent at any time. A copy ofthis consentform
has been given to me for my records.
(Signature of Participant)
(Signature of Witness)
(Date)
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